Detection of prostate cancer in symptomatic patients with prostate specific antigen between 4 and 10 ng/ml

被引:0
|
作者
Ravery, V
Schmid, HP
Billebaud, T
Toublanc, M
BocconGibod, L
Hermieu, JF
Delmas, V
BocconGibod, L
机构
[1] CHU BICHAT,SERV ANATOMOPATHOL,F-75877 PARIS 18,FRANCE
[2] HOP TROUSSEAU,SERV ANATOMOPATHOL,F-75571 PARIS,FRANCE
来源
PRESSE MEDICALE | 1996年 / 25卷 / 07期
关键词
MEN; CARCINOMA; AGE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Determine the incidence of prostate cancer in patients consulting for common miction disorders and serum prostatic specific antigen (PSA) between 4 and 10 ng/ml. Methods: A total of 153 patients consulted for miction disorders, In 107 of them, the digital examination was abnormal and PSA was between 3 and 10 ng/ml. Transrectal sonography and prostatic biopsies were performed in these 107 patients, We determined the number of cancers detected and assessed the contribution of PSA density (PSAD) to diagnosis, In patients undergoing radical prostatectomy, invasion of the capsule (C+) and positive exeresis section (M+) were recorded. Results: Cancer of the prostate was diagnosed in 29.4% of the patients on the basis of at least 1 of the 6 biopsies, This rate was 47.8% in patients with an abnormal and 21.5% with a normal digital examination, Radical prostatectomy was performed in 32 patients: 50% of them were C+ and 33% M+. Conclusion: Biopsy of the prostate is indicated in patients with an abnormal prostate at digital examination when PSA is between 4 and 10 ng/ml, When the prostate appears to be normal, PSAD may be helpful in determining when to perform a biopsy, Intermediary serum PSA levels do not guarantee favorable pathological characteristics.
引用
收藏
页码:272 / 276
页数:5
相关论文
共 50 条
  • [21] Our Prostate Biopsy Results in The Patients with Prostate Specific Antigen Levels Below 4 ng/ml
    Aydemir, Huseyin
    Budak, Salih
    Kumsar, Sukru
    Kose, Osman
    Saglam, Hasan Salih
    Adsan, Oztug
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2015, 6 (03) : 320 - 323
  • [22] Radical prostatectomy for prostate cancer patients with prostate-specific antigen >20 ng/ml
    Ou, YC
    Chen, JT
    Cheng, CL
    Ho, HC
    Yang, CR
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (11) : 574 - 579
  • [23] Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL)
    Chung, Jae Hoon
    Yu, Jiwoong
    Song, Wan
    Kang, Minyong
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Lee, Hyun Moo
    Jeon, Seong Soo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (41)
  • [24] A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
    Catalona, William J.
    Partin, Alan W.
    Sanda, Martin G.
    Wei, John T.
    Klee, George G.
    Bangma, Chris H.
    Slawin, Kevin M.
    Marks, Leonard S.
    Loeb, Stacy
    Broyles, Dennis L.
    Shin, Sanghyuk S.
    Cruz, Amabelle B.
    Chan, Daniel W.
    Sokoll, Lori J.
    Roberts, William L.
    van Schaik, Ron H. N.
    Mizrahi, Isaac A.
    JOURNAL OF UROLOGY, 2011, 185 (05): : 1650 - 1655
  • [25] Prostate-specific antigen levels of ≤4 and >4 ng/mL and risk of prostate cancer-specific mortality in men with biopsy Gleason score 9 to 10 prostate cancer
    Kim, Daniel W.
    Chen, Ming-Hui
    Wu, Jing
    Huland, Hartwig
    Graefen, Markus
    Tilki, Derya
    D'Amico, Anthony, V
    CANCER, 2021, 127 (13) : 2222 - 2228
  • [26] Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml
    Loeb, Stacy
    Roehl, Kimberly A.
    Nadler, Robert B.
    Yu, Xiaoying
    Catalona, William J.
    JOURNAL OF UROLOGY, 2007, 178 (06): : 2348 - 2352
  • [27] Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL
    Hong, Sung Kyu
    Oh, Jong Jin
    Byun, Seok-Soo
    Hwang, Sung Il
    Choo, Min Soo
    Lee, Sang Eun
    BJU INTERNATIONAL, 2012, 110 (2B) : E81 - E85
  • [28] Prostate cancer detection in the prostate specific antigen range of 2.0 to 3.9 ng/ml:: Value of percent free prostate specific antigen on tumor detection and tumor aggressiveness
    Raaijmakers, R
    Blijenberg, BG
    Finlay, JA
    Rittenhouse, HG
    Wildhagen, MF
    Roobol, MJ
    Schröder, FH
    JOURNAL OF UROLOGY, 2004, 171 (06): : 2245 - 2249
  • [29] Probability of prostate cancer as a function of the percentage of free prostate-specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4–10 ng/ml
    L. Martínez-Piñeiro
    J. M. García Mediero
    P. González Gancedo
    A. Tabernero
    D. Lozano
    J. J. López-Tello
    J. M. Alonso-Dorrego
    C. Núñez
    M. L. Picazo
    R. Madero
    J. J. De La Peña
    World Journal of Urology, 2004, 22 : 124 - 131
  • [30] The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4–10 ng/mL
    Xiang-Yi Zheng
    Li-Ping Xie
    Yu-Yong Wang
    Wei Ding
    Kai Yang
    Hua-Feng Shen
    Jie Qin
    Yu Bai
    Zhao-Dian Chen
    Journal of Cancer Research and Clinical Oncology, 2008, 134 : 1207 - 1210